[HLIND] QoQ Cumulative Quarter Result on 30-Jun-2010 [#4]

Stock
[HLIND] HONG LEONG INDUSTRIES BHD
Announcement Date
23-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2010
Quarter
30-Jun-2010 [#4]
Profit Trend
QoQ- 35.52%
YoY- 158.82%
Quarter Report
Latest QR
Upcoming QR
HLIND's Result
HLIND's Financial Summary
View:
Show?
Cumulative Result
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Revenue 1,265,804 828,614 402,125 1,485,576 2,106,848 1,389,161 671,957 52.58%
PBT 195,296 112,339 49,486 201,940 248,758 151,242 67,611 102.95%
Tax 38,268 44,423 21,044 91,616 -37,039 -21,025 -10,949 -
NP 233,564 156,762 70,530 293,556 211,719 130,217 56,662 157.30%
-
NP to SH 164,434 104,315 45,502 194,278 143,357 90,971 40,522 154.62%
-
Tax Rate -19.59% -39.54% -42.53% -45.37% 14.89% 13.90% 16.19% -
Total Cost 1,032,240 671,852 331,595 1,192,020 1,895,129 1,258,944 615,295 41.23%
-
Net Worth 1,136,343 1,443,878 1,417,361 1,389,007 1,365,304 1,326,115 1,305,389 -8.83%
Dividend
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Div 55,071 26,157 26,150 44,469 44,463 18,309 18,312 108.48%
Div Payout % 33.49% 25.08% 57.47% 22.89% 31.02% 20.13% 45.19% -
Equity
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Net Worth 1,136,343 1,443,878 1,417,361 1,389,007 1,365,304 1,326,115 1,305,389 -8.83%
NOSH 268,639 261,572 261,505 261,583 261,552 261,561 261,601 1.78%
Ratio Analysis
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
NP Margin 18.45% 18.92% 17.54% 19.76% 10.05% 9.37% 8.43% -
ROE 14.47% 7.22% 3.21% 13.99% 10.50% 6.86% 3.10% -
Per Share
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 471.19 316.78 153.77 567.92 805.52 531.10 256.86 49.90%
EPS 61.21 39.88 17.40 74.27 54.81 34.78 15.49 150.15%
DPS 20.50 10.00 10.00 17.00 17.00 7.00 7.00 104.82%
NAPS 4.23 5.52 5.42 5.31 5.22 5.07 4.99 -10.43%
Adjusted Per Share Value based on latest NOSH - 261,535
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 386.03 252.70 122.64 453.05 642.52 423.65 204.93 52.58%
EPS 50.15 31.81 13.88 59.25 43.72 27.74 12.36 154.60%
DPS 16.79 7.98 7.98 13.56 13.56 5.58 5.58 108.56%
NAPS 3.4655 4.4034 4.3225 4.236 4.1637 4.0442 3.981 -8.83%
Price Multiplier on Financial Quarter End Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 -
Price 4.01 5.35 5.20 4.54 4.66 4.53 3.77 -
P/RPS 0.85 1.69 3.38 0.80 0.58 0.85 1.47 -30.61%
P/EPS 6.55 13.42 29.89 6.11 8.50 13.02 24.34 -58.35%
EY 15.26 7.45 3.35 16.36 11.76 7.68 4.11 139.96%
DY 5.11 1.87 1.92 3.74 3.65 1.55 1.86 96.27%
P/NAPS 0.95 0.97 0.96 0.85 0.89 0.89 0.76 16.05%
Price Multiplier on Announcement Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 29/04/11 21/02/11 16/11/10 23/08/10 25/05/10 26/01/10 17/11/09 -
Price 3.82 5.72 5.20 5.07 4.31 4.67 4.32 -
P/RPS 0.81 1.81 3.38 0.89 0.54 0.88 1.68 -38.54%
P/EPS 6.24 14.34 29.89 6.83 7.86 13.43 27.89 -63.17%
EY 16.02 6.97 3.35 14.65 12.72 7.45 3.59 171.29%
DY 5.37 1.75 1.92 3.35 3.94 1.50 1.62 122.47%
P/NAPS 0.90 1.04 0.96 0.95 0.83 0.92 0.87 2.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment